Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children aged below 5 years in Germany
Authors
Dr. Jeanne Moor, CLINTEC Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
Department of General Internal Medicine, University Hospital Bern, Bern, Switzerland
Institute of Primary Health Care, University of Bern, Bern, Switzerland
PD Dr. Nicole Töpfner, Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Prof. Dr. Wolfgang C. G. von Meißner, Europäische Fachhochschule, Brühl, Germany
Institute of Family Medicine, University Medical Center Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
Prof. Dr. Reinhard Berner, Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
PD Dr. Matthias B. Moor, LABMED Division of Pathology, Karolinska Institutet, Stockholm, Sweden
CLINTEC Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
Prof. Dr. Karolina Kublickiene, CLINTEC Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
Dr. Christoph Strumann, Institute of Family Medicine, University Medical Center Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
PD Dr. Cho-Ming Chao , Department of Pediatrics, Helios University Medical Center, Witten/Herdecke University, Wuppertal, Germany. University Children's Hospital, University Medical Center Rostock, University of Rostock, Rostock, Germany, Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany
